India


IPU signs MoU with International Vaccine Institute, South Korea

IPU signs MoU with International Vaccine Institute, South Korea

New Delhi, May 17 (UNI) Guru Gobind Singh Indraprastha University (IPU) has signed a Memorandum of Understanding (MoU) with International Vaccine Institute (IVI), South Korea,
to facilitate discussion and establish a collaborative partnership in the areas of research,
training, and tool development related to vaccine studies.
With this agreement, both institutions will jointly engage in scientific and technical reviews, as
well as provide consultancy services in vaccine research and development, leveraging their respective areas of expertise.
Both will also collaborate to identify and pursue funding opportunities, prepare relevant documentation, and align their strategic priorities to enhance the impact of their joint
initiatives.
The institutions plan to co-organize workshops, seminars, and conferences on various topics
related to vaccines, further strengthening knowledge sharing and capacity building in this
critical field.
Speaking on the occasion, Vice Chancellor of the IP University Prof Mahesh Verma stated that this MoU will herald a new chapter in the field of research and development of novel vaccines.
Meanwhile, Prof Jerome Kim from the IVI also affirmed their commitment to fostering a strong and enduring collaborative relationship.
UNI RBE BM

More News

Vivekananda's thoughts accelerating building of developed India: Shah

13 Jan 2026 | 12:14 AM

New Delhi, Jan 12 (UNI) Remembering Swami Vivekananda on the occasion of his birth anniversary, Home Minister Amit Shah on Monday said that his thoughts, which convey the message of not stopping until one achieves the goal, are relevant even in the present day, and awakening a sense of duty and patriotism among the nation's youth.

see more..

Delhi IRL gets central certification to test key drugs for drug-resistant TB

13 Jan 2026 | 12:03 AM

Pankaj Jain
New Delhi, Jan 12 (UNI) Delhi’s Intermediate Reference Laboratory (IRL) at the New Delhi Tuberculosis Centre has achieved its first certification from the Central Tuberculosis Division (CTD), Government of India, to conduct Drug Susceptibility Testing (DST) for Bedaquiline (BDQ) and Pretomanid (Pa).

see more..

Delhi CM inaugurates National School Band Competition (Northern Zone) at Chhatrasal Stadium

12 Jan 2026 | 11:32 PM

New Delhi, Jan 12 (UNI) Delhi Chief Minister Rekha Gupta on Monday attended the inaugural ceremony of the National School Band Competition (Northern Zone) 2025–26 at Chhatrasal Stadium, where she was the Chief Guest.

see more..

Delhi Assembly Winter Session saw reduced paper usage: Speaker

12 Jan 2026 | 11:24 PM

New Delhi, Jan 12 (UNI) During the recent winter session of the Delhi Assembly, an internal assessment has shown significant environmental and financial savings due to reduced paper usage in one legislative session, Speaker Vijender Gupta has said.

see more..